Whitehouse Centers for Disease Control and Prevention US Department of Homeland Security - Federal Emergency Management Agency

Does (Veklury) remdesivir benefit patients with COVID-19?

The safety and efficacy of Veklury (remdesivir) for the treatment of COVID-19 are being evaluated in multiple ongoing clinical trials. Data from multiple phase 3 clinical trials suggest that Veklury (remdesivir) might benefit patients with COVID-19.

Last updated October 16, 2020
Source: U.S. Food & Drug Administrationlinks to external site

See also: Treatments, vaccines, and immunity